SMI
12.363,53
PKT
+56,64
PKT
+0,46
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.04.12 | Swiss Re underperform | RBC Capital Markets | |
| 18.04.12 | Swiss Re buy | Sarasin Research | |
| 17.04.12 | Sika neutral | Sarasin Research | |
| 17.04.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 16.04.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 12.04.12 | UBS underperform | Exane-BNP Paribas SA | |
| 12.04.12 | Holcim outperform | Cheuvreux SA | |
| 12.04.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 12.04.12 | Holcim underperform | Cheuvreux SA | |
| 11.04.12 | Givaudan sell | Deutsche Bank AG | |
| 11.04.12 | Novartis buy | UBS AG | |
| 11.04.12 | Givaudan neutral | Sarasin Research | |
| 10.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 10.04.12 | UBS underperform | Cheuvreux SA | |
| 10.04.12 | Sonova kaufen | Die Actien-Börse | |
| 05.04.12 | Holcim sell | Citigroup Corp. | |
| 05.04.12 | Nestlé overweight | HSBC | |
| 04.04.12 | UBS neutral | Credit Suisse Group | |
| 03.04.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 03.04.12 | Givaudan neutral | Nomura | |
| 03.04.12 | Zurich Insurance neutral | Sarasin Research | |
| 03.04.12 | Lonza neutral | Sarasin Research | |
| 03.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.04.12 | UBS buy | Goldman Sachs Group Inc. | |
| 02.04.12 | UBS neutral | Nomura | |
| 02.04.12 | UBS buy | Nomura | |
| 02.04.12 | Novartis buy | Sarasin Research | |
| 30.03.12 | UBS underperform | Exane-BNP Paribas SA | |
| 30.03.12 | UBS underperform | Exane-BNP Paribas SA | |
| 30.03.12 | Holcim neutral | HSBC | |
| 30.03.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 29.03.12 | Zurich Insurance neutral | Sarasin Research | |
| 29.03.12 | Swisscom neutral | Sarasin Research | |
| 29.03.12 | Holcim sell | ING | |
| 27.03.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 27.03.12 | Nestlé hold | ING | |
| 27.03.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 26.03.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 26.03.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 26.03.12 | UBS overweight | Morgan Stanley |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.